Amanote Research

Amanote Research

    RegisterSign In

Somatotype, the Risk of Hydroxychloroquine Retinopathy, and Safe Daily Dosing Guidelines

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s163451
Full Text
Open PDF
Abstract

Available in full text

Categories
Ophthalmology
Date

May 1, 2018

Authors
David J BrowningChong Lee
Publisher

Informa UK Limited


Related search

Chloroquine Retinopathy: Is There a Safe Daily Dose?

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1982English

Online Calculator for Hydroxychloroquine Dosing

Canadian Journal of Ophthalmology
MedicineOphthalmology
2020English

Royal College of Ophthalmologists Guidelines: Ocular Toxicity and Hydroxychloroquine

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
1998English

Guidelines and Adenosine Dosing in Supraventricular Tachycardia

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2005English

Single Versus Multiple Daily Dosing of Lithium

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2005English

Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence

Journal of Rheumatology
RheumatologyAllergyImmunology
2015English

BTS/SIGN Guidelines Query — Double Dosing

Primary Care Respiratory Journal
2003English

Daily Dosing for Bedaquiline in Patients With Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Physical Dependence Potential of Daily Tramadol Dosing in Humans

Psychopharmacology
Pharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy